{"id":"tpo-ras","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Thromboembolic events"},{"rate":null,"effect":"Bone marrow fibrosis (with long-term use)"}]},"_chembl":{"chemblId":"CHEMBL4303198","moleculeType":"Small molecule","molecularWeight":"405.35"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"TPO-RAs bind to and activate the thrombopoietin (TPO) receptor on megakaryocyte progenitor cells, promoting their proliferation and differentiation into mature megakaryocytes that produce platelets. This mechanism is used to treat thrombocytopenia by boosting endogenous platelet generation without requiring platelet transfusions.","oneSentence":"TPO-RAs (thrombopoietin receptor agonists) stimulate the thrombopoietin receptor to increase platelet production in the bone marrow.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:13:22.237Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Immune thrombocytopenia (ITP)"},{"name":"Thrombocytopenia associated with chronic liver disease"}]},"trialDetails":[{"nctId":"NCT07421167","phase":"PHASE2","title":"A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-06-29","conditions":"Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES)","enrollment":164},{"nctId":"NCT07206823","phase":"NA","title":"Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-09-01","conditions":"Primacy Immune Thrombocytopenia","enrollment":30},{"nctId":"NCT05466201","phase":"PHASE2, PHASE3","title":"The Use of Eltrombopag Post HSCT in BMFD","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-22","conditions":"Stem Cell Transplant Complications","enrollment":118},{"nctId":"NCT03119974","phase":"PHASE4","title":"Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-09-26","conditions":"Persistent or Chronic ITP","enrollment":48},{"nctId":"NCT02298075","phase":"","title":"Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia","status":"COMPLETED","sponsor":"Gruppo Italiano Malattie EMatologiche dell'Adulto","startDate":"2016-04","conditions":"Immune Thrombocytopenia","enrollment":148},{"nctId":"NCT06873672","phase":"","title":"Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-04-01","conditions":"Quality of Life (QOL), Patient-Reported Outcome Measures (PROMs), Pneumonia Childhood","enrollment":360},{"nctId":"NCT04890041","phase":"NA","title":"TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2021-05-30","conditions":"Primary Immune Thrombocytopenic Purpura","enrollment":100},{"nctId":"NCT05718856","phase":"PHASE4","title":"TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-02-23","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":166},{"nctId":"NCT04915482","phase":"PHASE2, PHASE3","title":"TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2021-06-06","conditions":"Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome","enrollment":94},{"nctId":"NCT05492409","phase":"PHASE3","title":"Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2022-03-28","conditions":"Idiopathic Thrombocytopenic Purpura","enrollment":160},{"nctId":"NCT05220878","phase":"PHASE3","title":"Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2021-09-09","conditions":"Idiopathic Thrombocytopenic Purpura","enrollment":160},{"nctId":"NCT05143892","phase":"PHASE2","title":"Avatrombopag to Promote Platelet Engraftment After Allo-HSCT","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-12-01","conditions":"Platelet Disorder","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":298,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TPO-R agonists"],"phase":"marketed","status":"active","brandName":"TPO-RAs","genericName":"TPO-RAs","companyName":"Institute of Hematology & Blood Diseases Hospital, China","companyId":"institute-of-hematology-blood-diseases-hospital-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TPO-RAs (thrombopoietin receptor agonists) stimulate the thrombopoietin receptor to increase platelet production in the bone marrow. Used for Immune thrombocytopenia (ITP), Thrombocytopenia associated with chronic liver disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}